FOR UK HEALTHCARE PROFESSIONALS ONLY

Cost Saving

By prescribing Sevodyne® by brand you could save 69% on your
current buprenorphine 7-day transdermal patches prescribing costs.1**

By prescribing Sevodyne by brand, the average savings for a CCG could still be £150,300 per year,2* providing the NHS with a total potential annual prescribing cost saving of approximately £19.8 million.2*

Sevodyne Cost Calculator

To find out how much you could save by prescribing Sevodyne, please follow the instructions on the Sevodyne calculator:

Sevodyne is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • 69% saving on UK Drug Tariffs price for buprenorphine transdermal patches1**
  • Available from mainline wholesalers
  • Pricing not dependent on competitor activity***
  • Price guaranteed***
ProductUK Drug Tariffs price1Sevodyne priceNHS Saving when Sevodyne is Prescribed
Buprenorphine transdermal patch 5 microgram/hr x 4£17.60 £5.53£12.07
Buprenorphine transdermal patch 10 microgram/hr x 4£31.55£9.93£21.62
Buprenorphine transdermal patch 15 microgram/hr x 4£49.15£15.48£33.67
Buprenorphine transdermal patch 20 microgram/hr x 4£57.46£18.09£39.37
*Savings based on market data in reference 2. Savings calculated from 2021 spend of 132 Healthboards/CCGs switching their generic and originator brand 5, 10, 15 and 20mcg buprenorphine transdermal patch prescriptions to Sevodyne. **Based on 69% saving on the cost of buprenorphine transdermal patches in the UK Drug Tariffs. ***No change in price subject to no material change to the products of the UK Drug Tariffs until the 2024 PPRS review.
References: 1) November 2021 UK Drug Tariffs. 2) Insypher Data July 2021 Based on Annual Moving Total (UK)

TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.

For further information please call: 01730 231148,
email: customerservices@aspirepharma.co.uk or visit www.aspirepharma.co.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148

For more information about Sevodyne, please see the abbreviated prescribing information.

Revision reference – Sevodyne_11_29.11.2021

More products available
in this range:
Click to view their
individual websites